Clene’s (CLNN) “Buy” Rating Reaffirmed at D. Boral Capital

Clene (NASDAQ:CLNN – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at D. Boral Capital in a note issued to investors on Thursday,Benzinga reports. They presently have a $23.00 price objective on the stock. Other equities analysts have also issued reports about the stock. HC Wainwright reiterated a “buy” rating and […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Initiates Coverage on Oxbridge Re (NASDAQ:OXBR)
Next post Ag Growth International (TSE:AFN) Price Target Raised to C$47.00